The Food and Drug Administration has revealed that the maker of a brand of eye drops linked to an outbreak of fatal bacterial infections failed to follow multiple safety protocols.
The FDA visited a Global Pharma Healthcare facility in India for an inspection in mid-February and found dozens of issues ranging from dirty equipment and clothing to missing safeguards and procedures.
The inspection came two-and-a-half weeks after the company voluntarily recalled the EzriCare artificial tears product because of possible contamination.
When the recall was issued, there were already 55 reports of adverse events, including eye infections, permanent loss of vision, and at least one death from a bloodstream infection.
When it comes to finding a job, the interview may cause the most anxiety for applicants. Cheddar News' docuseries, Ready 4 Work, speaks with job seekers who learn what to do when that all-important interview is remote.
Major averages rose in Wednesday's opening session but the Nasdaq fell after Alphabet reported cloud revenue below Wall Street estimates, despite topping profit views.
An off-duty commercial pilot riding in an extra cockpit seat on a Horizon Air flight said “I’m not OK” just before trying to cut the engines midflight and later told police he had recently taken psychedelic mushrooms as his mental health worsened, according to a federal complaint made public Tuesday.
